Oxidative stress and proteasome inhibitors in multiple myeloma

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Brittany C LipchickMikhail A Nikiforov

Abstract

Multiple myeloma is a form of plasma cell neoplasm that accounts for approximately 10% of all hematological malignancies. Recently, several novel drugs have been discovered that almost doubled the overall survival of multiple myeloma patients. One of these drugs, the first-in-class proteasome inhibitor bortezomib (Velcade) has demonstrated remarkable response rates in multiple myeloma patients, and yet, currently this disease remains incurable. The major factor undermining the success of multiple myeloma treatment is a rapidly emerging resistance to the available therapy. Thus, the development of stand-alone or adjuvant anti-myeloma agents becomes of paramount importance. Overproduction of intracellular reactive oxygen species (ROS) often accompanies malignant transformation due to oncogene activation and/or enhanced metabolism in tumor cells. As a result, these cells possess higher levels of ROS and lower levels of antioxidant molecules compared to their normal counterparts. Unbalanced production of ROS leads to oxidative stress which, if left unchecked, could be toxic for the cell. In multiple myeloma cells where high rates of immunoglobulin synthesis is an additional factor contributing to overproduction of ROS, further indu...Continue Reading

References

Apr 1, 1995·Free Radical Biology & Medicine·R H Burdon
Oct 12, 1999·Free Radical Research·K ItohM Yamamoto
Oct 18, 2000·Free Radical Biology & Medicine·E Cadenas, K J Davies
Dec 1, 2001·Free Radical Biology & Medicine·J Nordberg, E S Arnér
Dec 3, 2002·Nature Reviews. Cancer·Teru Hideshima, Kenneth C Anderson
Aug 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ann-Hwee LeeLaurie H Glimcher
Feb 6, 2004·The Journal of Cell Biology·Benjamin P Tu, Jonathan S Weissman
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xin-Yan PeiSteven Grant
Sep 8, 2004·Molecular Cell·Cole M HaynesAntony A Cooper
Sep 10, 2004·American Journal of Physiology. Cell Physiology·Paul S BrookesShey-Shing Sheu
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Mar 7, 2006·Critical Reviews in Clinical Laboratory Sciences·José M EstrelaElena Obrador
Jun 22, 2006·Acta Pharmacologica Sinica·Yuan YanJie Liu
Aug 30, 2006·British Journal of Haematology·Robert A Kyle, S Vincent Rajkumar
Oct 20, 2006·Apoptosis : an International Journal on Programmed Cell Death·Wei WangYasuhisa Shinomura
Jan 24, 2007·Physiological Reviews·Karen Bedard, Karl-Heinz Krause
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amanda F BakerGarth Powis
Jan 8, 2008·Anti-cancer Drugs·David LlobetXavier Dolcet
Jan 31, 2008·Neoplasia : an International Journal for Oncology Research·Jun CaiJing Yi
Feb 5, 2008·Biochimica Et Biophysica Acta·Silvia Masciarelli, Roberto Sitia
Mar 25, 2008·Therapeutics and Clinical Risk Management·Antonia Field-SmithFaith E Davies
Jun 25, 2008·The Journal of Cell Biology·Kai ChenJohn F Keaney
Oct 31, 2008·The Journal of Investigative Dermatology·Feng LiuFrank L Meyskens
Dec 9, 2008·The Biochemical Journal·Michael P Murphy
May 20, 2009·Leukemia & Lymphoma·Alpana SharmaLalit Kumar
Aug 22, 2009·The EMBO Journal·Hyun Jung ParkPradip Raychaudhuri
Jan 13, 2010·Experimental Gerontology·Martin D Brand
Apr 8, 2010·Free Radical Research·Geou-Yarh Liou, Peter Storz
May 1, 2010·Trends in Biochemical Sciences·Robert B Hamanaka, Navdeep S Chandel
May 12, 2010·Molecular and Cellular Biology·Ru-Feng WuLance S Terada

❮ Previous
Next ❯

Citations

Oct 30, 2016·European Journal of Pharmacology·Juergen KoesslerAnna Kobsar
Oct 25, 2016·International Journal of Molecular Sciences·Philip EganH Denis Alexander
Aug 18, 2018·Molecular Pharmacology·Keshav KarkiStephen Safe
Oct 1, 2019·Journal of Cellular and Molecular Medicine·Aikaterini SkordaIoannis P Trougakos
Sep 14, 2020·Asia-Pacific Journal of Clinical Oncology·Yang Bai, Xing Su
Sep 1, 2017·Cancer & Metabolism·Esther A ZaalCelia R Berkers
Mar 28, 2018·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Andrea IannacconeA Milan
May 2, 2019·Frontiers in Cell and Developmental Biology·Alfonso Serrano-Del ValleIsabel Marzo
Aug 21, 2020·Genome Research·Raquel OrdoñezJose I Martin-Subero
Nov 21, 2018·Frontiers in Oncology·Esther A Zaal, Celia R Berkers
Jul 9, 2020·Cancers·Hana SahinbegovicMichal Simicek
Jul 2, 2019·Cellular Signalling·Juergen KoesslerAnna Kobsar
Feb 19, 2021·Cellular and Molecular Life Sciences : CMLS·Sinan XiongJianbiao Zhou
Mar 14, 2021·Scientific Reports·Yana AisenJacob Bar-Tana
Apr 4, 2021·Cancers·Anaís Sánchez-CastilloKim R Kampen
May 24, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hangting HuTatiana K Bronich
May 1, 2021·Cancers·Alejandra Ortiz-RuizMiguel Gallardo
Jun 3, 2021·Cancers·Mélody CaillotBrigitte Sola

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

Current Opinion in Investigational Drugs
Pamela KanagasabaphyFaith E Davies
Expert Opinion on Pharmacotherapy
Michel Delforge
Leukemia & Lymphoma
Konstantinos AnargyrouEvangelos Terpos
Autophagy
Pedram KharazihaTheocharis Panaretakis
© 2021 Meta ULC. All rights reserved